Hims & Hers Health, Inc. (HIMS) Return on Equity (ROE): -2.97%
Is Hims & Hers Health, Inc.’s return on equity (ROE) high or low?
Hims & Hers Health, Inc.'s return on equity (ROE) of -2.97% is 836% below its 5-year average of 0.40%, around the middle of its 5-year range (-32.17%–26.44%).
The return on equity (ROE) for Hims & Hers Health, Inc. (HIMS) is -2.97% as of Wednesday, June 10, 2026. It is below its 12-month average by 111.84% (25.09%).
HIMS Return on Equity (ROE) Chart
HIMS Average Return on Equity (ROE) Chart
HIMS Current vs Average Return on Equity (ROE) Chart
HIMS Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
-2.97%
RETURN ON EQUITY (ROE) AVG TTM
25.09%
RETURN ON EQUITY (ROE) AVG 3Y
5.57%
RETURN ON EQUITY (ROE) AVG 5Y
0.40%
RETURN ON EQUITY (ROE) AVG 10Y
7.96%
RETURN ON EQUITY (ROE) AVG 15Y
7.96%
RETURN ON EQUITY (ROE) AVG 20Y
7.96%
CURRENT VS TTM AVG
-111.84%
CURRENT VS 3Y AVG
-153.37%
CURRENT VS 5Y AVG
-836.36%
CURRENT VS 10Y AVG
-137.33%
CURRENT VS 15Y AVG
-137.33%
CURRENT VS 20Y AVG
-137.33%
HIMS Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | — | -2.97% | 25.09% | 5.57% | 0.40% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.89B | 2.46% | -8.94% | -15.72% | 1.14% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | -6.28% | -2.13% | 6.32% | 9.65% |
| Align Technology, Inc. (ALGN) | $12.56B | 10.36% | 10.54% | 10.84% | 19.93% |
| Hologic, Inc. (HOLX) | $16.97B | 10.37% | 13.30% | 15.60% | 24.66% |
| Moderna, Inc. (MRNA) | $18.40B | -43.12% | -32.64% | -13.90% | 0.25% |
| BioNTech SE (BNTX) | $21.81B | -6.79% | -4.55% | 10.63% | 21.70% |
| Mettler-Toledo International Inc. (MTD) | $22.85B | -3677.41% | -2178.82% | -341.14% | -117.12% |
| Waters Corporation (WAT) | $23.83B | 2.94% | 29.98% | 64.02% | 111.55% |
| Veeva Systems Inc. (VEEV) | $27.37B | 12.60% | 12.42% | 12.32% | 13.45% |
Return Analysis
ROE
-3.0%
ROA
-0.6%
Hims & Hers Health, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hims & Hers Health, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The return on equity (ROE) for HIMS stock is -2.97%.
- Is Hims & Hers Health, Inc.'s return on equity (ROE) high or low?
- Hims & Hers Health, Inc.'s return on equity (ROE) of -2.97% is 836% below its 5-year average of 0.40%, around the middle of its 5-year range (-32.17%–26.44%).
- What is the TTM average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The TTM average return on equity (ROE) for HIMS stock is 25.09%.
- What is the 3Y average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The 3Y average return on equity (ROE) for HIMS stock is 5.57%.
- What is the 5Y average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The 5Y average return on equity (ROE) for HIMS stock is 0.40%.
- What is the 10Y average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The 10Y average return on equity (ROE) for HIMS stock is 7.96%.
- What is the 15Y average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The 15Y average return on equity (ROE) for HIMS stock is 7.96%.
- What is the 20Y average return on equity (ROE) for Hims & Hers Health, Inc. (HIMS)?
- The 20Y average return on equity (ROE) for HIMS stock is 7.96%.
Hims & Hers Health, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 23.73% |
| 2024-12-31 | 26.44% |
| 2023-12-31 | -6.84% |
| 2022-12-31 | -21.07% |
| 2021-12-31 | -32.17% |
| 2020-12-31 | 12.33% |
| 2019-12-31 | 53.27% |
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum